My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 45

    1.

    Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study.

    Santini D, Tampellini M, Vincenzi B, Ibrahim T, Ortega C, Virzi V, Silvestris N, Berardi R, Masini C, Calipari N, Ottaviani D, Catalano V, Badalamenti G, Giannicola R, Fabbri F, Venditti O, Fratto ME, Mazzara C, Latiano TP, Bertolini F, Petrelli F, Ottone A, Caroti C, Salvatore L, Falcone A, Giordani P, Addeo R, Aglietta M, Cascinu S, Barni S, Maiello E, Tonini G.

    Ann Oncol. 2012 Feb 7. [Epub ahead of print]

    PMID:
    22219016
    [PubMed - as supplied by publisher]

    Related citations

    2.

    FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer-subgroup analysis of patients with KRAS: mutated tumours in the randomised German AIO study KRK-0306.

    Stintzing S, Fischer von Weikersthal L, Decker T, Vehling-Kaiser U, Jäger E, Heintges T, Stoll C, Giessen C, Modest DP, Neumann J, Jung A, Kirchner T, Scheithauer W, Heinemann V.

    Ann Oncol. 2012 Jan 4. [Epub ahead of print]

    PMID:
    22219013
    [PubMed - as supplied by publisher]

    Related citations

    3.

    Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab.

    Scartozzi M, Giampieri R, Maccaroni E, Mandolesi A, Giustini L, Silva R, Zaniboni A, Biscotti T, Biagetti S, Galizia E, Loupakis F, Falcone A, Bearzi I, Cascinu S.

    Ann Oncol. 2011 Nov 23. [Epub ahead of print]

    PMID:
    22112971
    [PubMed - as supplied by publisher]

    Related citations

    4.

    Serial FDG-PET/CT for early outcome prediction in patients with metastatic colorectal cancer undergoing chemotherapy.

    Hendlisz A, Golfinopoulos V, Garcia C, Covas A, Emonts P, Ameye L, Paesmans M, Deleporte A, Machiels G, Toussaint E, Vanderlinden B, Awada A, Piccart M, Flamen P.

    Ann Oncol. 2011 Nov 23. [Epub ahead of print]

    PMID:
    22112970
    [PubMed - as supplied by publisher]

    Related citations

    5.

    The ARCAD advanced colorectal cancer database--open for business.

    Buyse M, Sargent DJ, Goldberg RM, de Gramont A; ARCAD Clinical Trials Program.

    Ann Oncol. 2012 Jan;23(1):281-2. Epub 2011 Nov 21. No abstract available.

    PMID:
    22104572
    [PubMed - indexed for MEDLINE]

    Related citations

    6.

    Fasting glucose and treatment outcome in breast and colorectal cancer patients treated with targeted agents: results from a historic cohort.

    Barba M, Sperati F, Stranges S, Carlomagno C, Nasti G, Iaffaioli V, Caolo G, Mottolese M, Botti G, Terrenato I, Vici P, Serpico D, Giordano A, D'Aiuto G, Crispo A, Montella M, Capurso G, Delle Fave G, Fuhrman B, Botti C, De Placido S.

    Ann Oncol. 2011 Nov 18. [Epub ahead of print]

    PMID:
    22100694
    [PubMed - as supplied by publisher]

    Related citations

    7.

    Phase II study of panitumumab, oxaliplatin, 5-fluorouracil, and concurrent radiotherapy as preoperative treatment in high-risk locally advanced rectal cancer patients (StarPan/STAR-02 Study).

    Pinto C, Di Fabio F, Maiello E, Pini S, Latiano T, Aschele C, Garufi C, Bochicchio A, Rosati G, Aprile G, Giaquinta S, Torri V, Bardelli A, Gion M, Martoni A.

    Ann Oncol. 2011 Nov;22(11):2424-30. Epub 2011 Mar 8.

    PMID:
    21385884
    [PubMed - indexed for MEDLINE]

    Related citations

    8.

    PIK3CA exon 20 mutations as a potential biomarker for resistance to anti-EGFR monoclonal antibodies in KRAS wild-type metastatic colorectal cancer: a systematic review and meta-analysis.

    Mao C, Yang ZY, Hu XF, Chen Q, Tang JL.

    Ann Oncol. 2012 Jun;23(6):1518-25. Epub 2011 Oct 29.

    PMID:
    22039088
    [PubMed - in process]

    Related citations

    9.

    Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C.

    Price TJ, Zannino D, Wilson K, Simes RJ, Cassidy J, Van Hazel GA, Robinson BA, Broad A, Ganju V, Ackland SP, Tebbutt NC.

    Ann Oncol. 2012 Jun;23(6):1531-6. Epub 2011 Oct 29.

    PMID:
    22039086
    [PubMed - in process]

    Related citations

    10.

    Comparison of toxicity profiles of fluorouracil versus oxaliplatin regimens in a large population-based cohort of elderly patients with colorectal cancer.

    Cen P, Liu C, Du XL.

    Ann Oncol. 2012 Jun;23(6):1503-11. Epub 2011 Oct 21.

    PMID:
    22021820
    [PubMed - in process]

    Related citations

    11.

    Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy.

    Klaver YL, Lemmens VE, Creemers GJ, Rutten HJ, Nienhuijs SW, de Hingh IH.

    Ann Oncol. 2011 Oct;22(10):2250-6. Epub 2011 Feb 23.

    PMID:
    21345939
    [PubMed - indexed for MEDLINE]

    Related citations

    12.

    Prognostic value of preoperative radiological staging assessed by computed tomography in patients with nonmetastatic colon cancer.

    Huh JW, Jeong YY, Kim HR, Kim YJ.

    Ann Oncol. 2012 May;23(5):1198-206. Epub 2011 Sep 23.

    PMID:
    21948813
    [PubMed - in process]

    Related citations

    13.

    Celecoxib can prevent capecitabine-related hand-foot syndrome in stage II and III colorectal cancer patients: result of a single-center, prospective randomized phase III trial.

    Zhang RX, Wu XJ, Wan DS, Lu ZH, Kong LH, Pan ZZ, Chen G.

    Ann Oncol. 2012 May;23(5):1348-53. Epub 2011 Sep 22.

    PMID:
    21940785
    [PubMed - in process]

    Related citations

    14.

    An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients.

    Crea F, Fornaro L, Paolicchi E, Masi G, Frumento P, Loupakis F, Salvatore L, Cremolini C, Schirripa M, Graziano F, Ronzoni M, Ricci V, Farrar WL, Falcone A, Danesi R.

    Ann Oncol. 2012 May;23(5):1207-13. Epub 2011 Sep 16.

    PMID:
    21926398
    [PubMed - in process]

    Related citations

    15.

    Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy.

    Twelves C, Scheithauer W, McKendrick J, Seitz JF, Van Hazel G, Wong A, Díaz-Rubio E, Gilberg F, Cassidy J.

    Ann Oncol. 2012 May;23(5):1190-7. Epub 2011 Sep 6.

    PMID:
    21896539
    [PubMed - in process]

    Related citations

    16.

    A multicentre study of capecitabine, oxaliplatin plus bevacizumab as perioperative treatment of patients with poor-risk colorectal liver-only metastases not selected for upfront resection.

    Wong R, Cunningham D, Barbachano Y, Saffery C, Valle J, Hickish T, Mudan S, Brown G, Khan A, Wotherspoon A, Strimpakos AS, Thomas J, Compton S, Chua YJ, Chau I.

    Ann Oncol. 2011 Sep;22(9):2042-8. Epub 2011 Feb 1.

    PMID:
    21285134
    [PubMed - indexed for MEDLINE]

    Related citations

    17.

    The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy.

    Suzuki C, Blomqvist L, Sundin A, Jacobsson H, Byström P, Berglund Å, Nygren P, Glimelius B.

    Ann Oncol. 2012 Apr;23(4):948-54. Epub 2011 Aug 10.

    PMID:
    21832285
    [PubMed - in process]

    Related citations

    18.

    Cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer: results from the randomised phase II part of a phase I/II study.

    Kato T, Muro K, Yamaguchi K, Bando H, Hazama S, Amagai K, Baba H, Denda T, Shi X, Fukase K, Sakamoto J, Mishima H.

    Ann Oncol. 2012 Apr;23(4):933-41. Epub 2011 Aug 9.

    PMID:
    21828378
    [PubMed - in process]

    Related citations

    19.

    Clinical value of circulating endothelial cell levels in metastatic colorectal cancer patients treated with first-line chemotherapy and bevacizumab.

    Malka D, Boige V, Jacques N, Vimond N, Adenis A, Boucher E, Pierga JY, Conroy T, Chauffert B, François E, Guichard P, Galais MP, Cvitkovic F, Ducreux M, Farace F.

    Ann Oncol. 2012 Apr;23(4):919-27. Epub 2011 Aug 8.

    PMID:
    21825101
    [PubMed - in process]

    Related citations

    20.

    Adjuvant capecitabine chemotherapy using a tailored-dose strategy in elderly patients with colon cancer.

    Chang HJ, Lee KW, Kim JH, Bang SM, Kim YJ, Kim DW, Kang SB, Lee JS.

    Ann Oncol. 2012 Apr;23(4):911-8. Epub 2011 Aug 4.

    PMID:
    21821549
    [PubMed - in process]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk